in Newswire Published on April 22, 2019

Class Action Over Quincy Bioscience’s Prevagen Brain Health Claims Transferred to New York

Spath v. Quincy Bioscience Holding Company, Inc. et al.

Filed: April 22, 2019 § 1:19-cv-03521

A class action filed in August 2018 claims Quincy Bioscience falsely misrepresented the apparent brain heath benefits of Prevagen.

Case Spotlight

Hair Relaxer Lawsuits

How Do I Join a Class Action Lawsuit?

ClassAction.org Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on April 22, 2019 — 4:24 PM

Corrado Rizzi

corrado@classaction.org

Corrado Rizzi is the Senior Managing Editor of ClassAction.org.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.